Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 1.2x - 1.3x | 1.3x |
| Selected Fwd Ps Multiple | 0.5x - 0.6x | 0.6x |
| Fair Value | ₩5,328 - ₩5,888 | ₩5,608 |
| Upside | 59.0% - 75.8% | 67.4% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| INSAN Inc. | - | KOSDAQ:A277410 |
| Icure Pharmaceutical Incorporation | - | KOSDAQ:A175250 |
| Cosmecca Korea Co., Ltd. | - | KOSDAQ:A241710 |
| Manyo Factory Co., Ltd | - | KOSDAQ:A439090 |
| Hankook Cosmetics Co., Ltd. | - | KOSE:A123690 |
| Jayjun Cosmetic Co., Ltd. | - | KOSE:A025620 |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| A277410 | A175250 | A241710 | A439090 | A123690 | A025620 | |||
| KOSDAQ:A277410 | KOSDAQ:A175250 | KOSDAQ:A241710 | KOSDAQ:A439090 | KOSE:A123690 | KOSE:A025620 | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 4.7% | 11.3% | 9.2% | NM- | -12.5% | -33.6% | ||
| 3Y CAGR | -5.3% | -14.3% | 11.6% | NM- | 2.8% | -17.7% | ||
| Latest Twelve Months | -12.9% | 1.7% | 14.1% | 30.7% | 20.5% | 61.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 12.6% | -42.4% | 3.7% | 14.1% | -5.4% | -179.9% | ||
| Prior Fiscal Year | 13.3% | -70.4% | 0.7% | 17.0% | 0.9% | -308.1% | ||
| Latest Fiscal Year | 2.7% | -55.3% | 4.7% | 11.1% | 4.5% | -39.9% | ||
| Latest Twelve Months | 2.7% | 0.9% | 6.9% | 12.6% | 2.7% | -43.9% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 22.3x | -3.9x | 7.9x | 11.7x | 24.0x | -2.9x | ||
| Price / LTM Sales | 1.4x | 1.0x | 0.9x | 2.5x | 1.2x | 0.8x | ||
| LTM P/E Ratio | 52.9x | 112.4x | 13.8x | 19.7x | 45.6x | -1.8x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 0.9x | 1.2x | 2.5x | |||||
| Historical LTM P/S Ratio | 2.0x | 2.7x | 4.1x | |||||
| Selected Price / Sales Multiple | 1.2x | 1.3x | 1.3x | |||||
| (x) LTM Sales | 19,372 | 19,372 | 19,372 | |||||
| (=) Equity Value | 23,292 | 24,518 | 25,744 | |||||
| (/) Shares Outstanding | 4.5 | 4.5 | 4.5 | |||||
| Implied Value Range | 5,205.72 | 5,479.70 | 5,753.69 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 5,205.72 | 5,479.70 | 5,753.69 | 3,350.00 | ||||
| Upside / (Downside) | 55.4% | 63.6% | 71.8% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A277410 | A175250 | A241710 | A439090 | A123690 | A025620 | |
| Value of Common Equity | 46,740 | 59,642 | 492,348 | 318,066 | 111,345 | 14,989 | |
| (/) Shares Outstanding | 37.7 | 37.4 | 10.7 | 16.4 | 16.1 | 4.5 | |
| Implied Stock Price | 1,240.00 | 1,596.00 | 46,100.00 | 19,420.00 | 6,930.00 | 3,350.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1,240.00 | 1,596.00 | 46,100.00 | 19,420.00 | 6,930.00 | 3,350.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |